| Unique ID issued by UMIN | UMIN000059857 |
|---|---|
| Receipt number | R000067974 |
| Scientific Title | Development and Performance Validation of Artificial Intelligence-Assisted Image Analysis Software for the Diagnosis of Gastric Intestinal Metaplasia |
| Date of disclosure of the study information | 2025/12/01 |
| Last modified on | 2025/11/22 16:45:47 |
Development and Performance Validation of Artificial Intelligence-Assisted Image Analysis Software for the Diagnosis of Gastric Intestinal Metaplasia
Development and Validation of an AI System for Diagnosing Gastric Intestinal Metaplasia
Development and Performance Validation of Artificial Intelligence-Assisted Image Analysis Software for the Diagnosis of Gastric Intestinal Metaplasia
Development and Validation of an AI System for Diagnosing Gastric Intestinal Metaplasia
| Japan |
gastric intestinal metaplasia
| Gastroenterology |
Others
NO
The aim of this study is to develop and validate an AI-assisted image analysis software for the diagnosis of gastric intestinal metaplasia.
Efficacy
Diagnostic sensitivity of the developed AI for gastric intestinal metaplasia
1. Diagnostic specificity of gastric intestinal metaplasia (IM) by the developed AI
2. Diagnostic sensitivity and specificity of IM based on physicians' endoscopic diagnosis
3. Concordance rate of OLGA/OLGIM grading between the developed AI and histopathology
4. Concordance rate of OLGA/OLGIM grading between physicians' endoscopic diagnosis and histopathology
5. Diagnostic sensitivity and specificity of IM using the virtual chromoendoscopy program
6. Diagnostic accuracy of IM stratified by physicians' level of experience
7. Diagnostic accuracy of IM stratified by patient characteristics
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
| Maneuver |
Two biopsies of the gastric mucosa for histopathological confirmation of intestinal metaplasia.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Patients aged 18 years or older.
2. Patients who meet either of the following conditions (i) or (ii):
(i) Patients diagnosed with atrophic gastritis (AG) or intestinal metaplasia (IM) in previous endoscopic examinations.
(ii) Patients currently infected with Helicobacter pylori or who have undergone eradication therapy in the past.
3. Patients from whom written informed consent for participation in this study has been obtained.
1. Patients who are unable to discontinue antithrombotic medication.
2. Pregnant women or women who may be pregnant.
3. Others.
400
| 1st name | Sho |
| Middle name | |
| Last name | Suzuki |
International University of Health and Welfare, Ichikawa Hospital
Gastroenterology
272-0827
6-1-14 Kokubunadai, Ichikawa-shi, Chiba 272-0827, Japan
047-375-1111
s.sho.salubriter.mail@gmail.com
| 1st name | Sho |
| Middle name | |
| Last name | Suzuki |
International University of Health and Welfare, Ichikawa Hospital
Gastroenterology
272-0827
6-1-14 Kokubunadai, Ichikawa-shi, Chiba, Japan
047-375-1111
s.sho.salubriter.mail@gmail.com
International University of Health and Welfare
AI Medical Service Inc.
Profit organization
International University of Health and Welfare Chiba District Ethics Review Committee
4-3 Kozunomori, Narita-shi, Chiba, Japan
0476-20-7701
rinri_md@ihwg.jp
NO
国際医療福祉大学市川病院(千葉県)、国際医療福祉大学成田病院(千葉県)
| 2025 | Year | 12 | Month | 01 | Day |
Unpublished
Preinitiation
| 2025 | Year | 11 | Month | 13 | Day |
| 2025 | Year | 11 | Month | 14 | Day |
| 2025 | Year | 12 | Month | 01 | Day |
| 2029 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 11 | Month | 22 | Day |
| 2025 | Year | 11 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000067974